Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Insights and Forecast to 2031

Report ID: 1639302 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Niraparib (Zejula)
        1.2.3 Olaparib (Lynparza)
        1.2.4 Rucaparib (Rubraca)
        1.2.5 Talazoparib (Talzenna)
    1.3 Market by Application
        1.3.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Perspective (2017-2028)
    2.2 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Growth Trends by Region
        2.2.1 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Historic Market Size by Region (2017-2022)
        2.2.3 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Region (2023-2028)
    2.3 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Dynamics
        2.3.1 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Industry Trends
        2.3.2 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Drivers
        2.3.3 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Challenges
        2.3.4 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players by Revenue
        3.1.1 Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players by Revenue (2017-2022)
        3.1.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Players (2017-2022)
    3.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue
    3.4 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Concentration Ratio
        3.4.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue in 2021
    3.5 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Key Players Head office and Area Served
    3.6 Key Players Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product Solution and Service
    3.7 Date of Enter into Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Breakdown Data by Type
    4.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Historic Market Size by Type (2017-2022)
    4.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Type (2023-2028)
5 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Breakdown Data by Application
    5.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Historic Market Size by Application (2017-2022)
    5.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2017-2028)
    6.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
        6.2.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022)
        6.2.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028)
        6.2.3 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2017-2028)
    6.3 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
        6.3.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022)
        6.3.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028)
        6.3.3 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2017-2028)
    6.4 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country
        6.4.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2017-2022)
        6.4.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2017-2028)
    7.2 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
        7.2.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022)
        7.2.2 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028)
        7.2.3 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2017-2028)
    7.3 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
        7.3.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022)
        7.3.2 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028)
        7.3.3 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2017-2028)
    7.4 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country
        7.4.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2017-2022)
        7.4.2 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2017-2028)
    8.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
        8.2.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2017-2028)
    8.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
        8.3.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2017-2028)
    8.4 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region
        8.4.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2017-2028)
    9.2 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
        9.2.1 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022)
        9.2.2 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028)
        9.2.3 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2017-2028)
    9.3 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
        9.3.1 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022)
        9.3.2 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028)
        9.3.3 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2017-2028)
    9.4 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country
        9.4.1 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2017-2022)
        9.4.2 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2017-2028)
    10.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
        10.2.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2017-2028)
    10.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
        10.3.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2017-2028)
    10.4 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country
        10.4.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.1.4 AstraZeneca Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.1.5 AstraZeneca Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Company Details
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.2.4 Pfizer Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.2.5 Pfizer Recent Developments
    11.3 Takeda
        11.3.1 Takeda Company Details
        11.3.2 Takeda Business Overview
        11.3.3 Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.3.4 Takeda Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.3.5 Takeda Recent Developments
    11.4 Abbvie
        11.4.1 Abbvie Company Details
        11.4.2 Abbvie Business Overview
        11.4.3 Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.4.4 Abbvie Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.4.5 Abbvie Recent Developments
    11.5 Clovis
        11.5.1 Clovis Company Details
        11.5.2 Clovis Business Overview
        11.5.3 Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.5.4 Clovis Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.5.5 Clovis Recent Developments
    11.6 BeiGene
        11.6.1 BeiGene Company Details
        11.6.2 BeiGene Business Overview
        11.6.3 BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.6.4 BeiGene Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.6.5 BeiGene Recent Developments
    11.7 Hansoh
        11.7.1 Hansoh Company Details
        11.7.2 Hansoh Business Overview
        11.7.3 Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.7.4 Hansoh Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.7.5 Hansoh Recent Developments
    11.8 Jeil
        11.8.1 Jeil Company Details
        11.8.2 Jeil Business Overview
        11.8.3 Jeil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.8.4 Jeil Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.8.5 Jeil Recent Developments
    11.9 Oncology
        11.9.1 Oncology Company Details
        11.9.2 Oncology Business Overview
        11.9.3 Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.9.4 Oncology Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.9.5 Oncology Recent Developments
    11.10 Shin Poong
        11.10.1 Shin Poong Company Details
        11.10.2 Shin Poong Business Overview
        11.10.3 Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
        11.10.4 Shin Poong Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
        11.10.5 Shin Poong Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Niraparib (Zejula)
    Table 3. Key Players of Olaparib (Lynparza)
    Table 4. Key Players of Rucaparib (Rubraca)
    Table 5. Key Players of Talazoparib (Talzenna)
    Table 6. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Region (2017-2022)
    Table 10. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Region (2023-2028)
    Table 12. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Trends
    Table 13. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Drivers
    Table 14. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Challenges
    Table 15. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Restraints
    Table 16. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Players (2017-2022)
    Table 18. Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor as of 2021)
    Table 19. Ranking of Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product Solution and Service
    Table 23. Date of Enter into Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Type (2017-2022)
    Table 27. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Type (2023-2028)
    Table 29. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Application (2017-2022)
    Table 31. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Share by Application (2023-2028)
    Table 33. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2023-2028) & (US$ Million)
    Table 63. AstraZeneca Company Details
    Table 64. AstraZeneca Business Overview
    Table 65. AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 66. AstraZeneca Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 67. AstraZeneca Recent Developments
    Table 68. Pfizer Company Details
    Table 69. Pfizer Business Overview
    Table 70. Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 71. Pfizer Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 72. Pfizer Recent Developments
    Table 73. Takeda Company Details
    Table 74. Takeda Business Overview
    Table 75. Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 76. Takeda Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 77. Takeda Recent Developments
    Table 78. Abbvie Company Details
    Table 79. Abbvie Business Overview
    Table 80. Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 81. Abbvie Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 82. Abbvie Recent Developments
    Table 83. Clovis Company Details
    Table 84. Clovis Business Overview
    Table 85. Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 86. Clovis Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 87. Clovis Recent Developments
    Table 88. BeiGene Company Details
    Table 89. BeiGene Business Overview
    Table 90. BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 91. BeiGene Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 92. BeiGene Recent Developments
    Table 93. Hansoh Company Details
    Table 94. Hansoh Business Overview
    Table 95. Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 96. Hansoh Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 97. Hansoh Recent Developments
    Table 98. Jeil Company Details
    Table 99. Jeil Business Overview
    Table 100. Jeil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 101. Jeil Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 102. Jeil Recent Developments
    Table 103. Oncology Company Details
    Table 104. Oncology Business Overview
    Table 105. Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 106. Oncology Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 107. Oncology Recent Developments
    Table 108. Shin Poong Company Details
    Table 109. Shin Poong Business Overview
    Table 110. Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
    Table 111. Shin Poong Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022) & (US$ Million)
    Table 112. Shin Poong Recent Developments
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type: 2021 VS 2028
    Figure 2. Niraparib (Zejula) Features
    Figure 3. Olaparib (Lynparza) Features
    Figure 4. Rucaparib (Rubraca) Features
    Figure 5. Talazoparib (Talzenna) Features
    Figure 6. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application: 2021 VS 2028
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Report Years Considered
    Figure 11. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Region: 2021 VS 2028
    Figure 14. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Players in 2021
    Figure 15. Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue in 2021
    Figure 17. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Type (2017-2028)
    Figure 19. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Application (2017-2028)
    Figure 20. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Share by Country (2017-2028)
    Figure 21. United States Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Share by Country (2017-2028)
    Figure 27. Germany Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Share by Region (2017-2028)
    Figure 37. China Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Share by Country (2017-2028)
    Figure 47. Mexico Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Share by Country (2017-2028)
    Figure 53. Turkey Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. AstraZeneca Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 58. Takeda Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 59. Abbvie Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 60. Clovis Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 61. BeiGene Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 62. Hansoh Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 63. Jeil Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 64. Oncology Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 65. Shin Poong Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Pfizer
Takeda
Abbvie
Clovis
BeiGene
Hansoh
Jeil
Oncology
Shin Poong
Frequently Asked Questions
Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

AV-over-IP Encoder

AV-over-IP Encoder market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

AV-over-IP Decoder

AV-over-IP Decoder market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

AVoIP

AVoIP market is segmented by players, region (country), by Type and by Application. Players, stak ... Read More